semaglutide generic india Indian Pharma Billionaires Pile Into Weight-Loss Drugs, Sparking Regulatory Scrutiny India's Dr Reddy's plans to

Of all the new companies requesting LegitScript certification in 2024, Roth says over 60 percent offer weight-loss drugs, and 98 percent of those companies offer compounded GLP-1 medications

The two forms are not interchangeable in dose or schedule

Additionally, when comparing Mounjaro vs Ozempic for weight loss, clinical trials suggest that Mounjaro may lead to greater weight reduction

Gastrointestinal side effects are the most frequently reported adverse reactions to GLP-1 receptor agonists, affecting a significant proportion of patients, particularly during initial treatment or dose escalation

Others, like the incretin mimetic semaglutide, regulate blood sugar and appetite levels, with applications in diabetes and obesity management [21]